Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Halo Collective Inc. (NEO: HALO) (OTCQB:HCANF) (Germany: A9KN) announced its financial and operational results for the fourth quarter and full year ended December 31, 2021.
Halo's "Seed to Sale" strategy in California accelerated as the Company delivered on its Los Angeles retail rollout in early 2022.
On March 18, 2022, Halo announced that the first Budega dispensary officially opened in the Arts District of North Hollywood, California.
Management anticipates opening stores in Westwood and Hollywood during in the spring and summer of 2022.
In fiscal 2022, Halo is planning to execute a strategy of incubating promising companies within the cannabis industry and the broader wellness space.
Akanda Corp. is the most advanced in its execution but there are other initiatives at earlier stages underway with the Company's interests in software, California cultivation, and CBD and functional beverages, that collectively the Company expects will enhance its financial strength.
“In 2020 we purchased two disparate international cannabis assets, Bophelo Bioscience & Wellness and CanMart and, after completing a reorganization of these assets and putting in place a team, strategy and structure, Halo is now the largest shareholder in this rapidly scaling international medical cannabis company with a stake worth over $100 million based on Akanda's current market capitalization,” said CEO Kiran Sidhu. “We are now assessing other opportunities with respect to Halo's investments in cannabis businesses ancillary to our West Coast operations, including our investments in CBD and functional beverages, two of the fastest-growing categories in the consumer space that can be widely distributed."
Photo: Couresy of Sharon McCutcheon on Unsplash
Posted In: HCANF